These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19859041)

  • 1. Clinically-relevent orthotopic metastatic models of pancreatic cancer imageable with fluorescent genetic reporters.
    Bouvet M; Hoffman RM
    Minerva Chir; 2009 Oct; 64(5):521-39. PubMed ID: 19859041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo imaging of pancreatic cancer with fluorescent proteins in mouse models.
    Bouvet M; Hoffman RM
    Methods Mol Biol; 2012; 872():51-67. PubMed ID: 22700403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor imaging technologies in mouse models.
    Bouvet M; Hoffman RM
    Methods Mol Biol; 2015; 1267():321-48. PubMed ID: 25636477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging the microenvironment of pancreatic cancer patient-derived orthotopic xenografts (PDOX) growing in transgenic nude mice expressing GFP, RFP, or CFP.
    Hoffman RM; Bouvet M
    Cancer Lett; 2016 Sep; 380(1):349-55. PubMed ID: 26742463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An imageable highly metastatic orthotopic red fluorescent protein model of pancreatic cancer.
    Katz MH; Takimoto S; Spivack D; Moossa AR; Hoffman RM; Bouvet M
    Clin Exp Metastasis; 2004; 21(1):7-12. PubMed ID: 15065597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherapy.
    Hoffman RM
    Methods Mol Med; 2005; 111():297-322. PubMed ID: 15911987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model.
    Bouvet M; Wang J; Nardin SR; Nassirpour R; Yang M; Baranov E; Jiang P; Moossa AR; Hoffman RM
    Cancer Res; 2002 Mar; 62(5):1534-40. PubMed ID: 11888932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronologically-specific metastatic targeting of human pancreatic tumors in orthotopic models.
    Bouvet M; Yang M; Nardin S; Wang X; Jiang P; Baranov E; Moossa AR; Hoffman RM
    Clin Exp Metastasis; 2000; 18(3):213-8. PubMed ID: 11315094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Establishment of red fluorescent protein orthotopic transplantation nude mice metastasis model of pancreatic cancer and whole-body fluorescent imaging].
    Yu ZQ; Zhou JH; Tao KT; Hu L; Zheng J; Yang DT
    Zhonghua Wai Ke Za Zhi; 2009 Jul; 47(14):1092-5. PubMed ID: 19781277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-color palette of fluorescent proteins for imaging the tumor microenvironment of orthotopic tumorgraft mouse models of clinical pancreatic cancer specimens.
    Suetsugu A; Katz M; Fleming J; Truty M; Thomas R; Moriwaki H; Bouvet M; Saji S; Hoffman RM
    J Cell Biochem; 2012 Jul; 113(7):2290-5. PubMed ID: 22573550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics.
    Katz MH; Takimoto S; Spivack D; Moossa AR; Hoffman RM; Bouvet M
    J Surg Res; 2003 Jul; 113(1):151-60. PubMed ID: 12943825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor imaging with multicolor fluorescent protein expression.
    Yamamoto N; Tsuchiya H; Hoffman RM
    Int J Clin Oncol; 2011 Apr; 16(2):84-91. PubMed ID: 21347627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Labeling the Stroma of a Patient-Derived Orthotopic Xenograft (PDOX) Mouse Model of Undifferentiated Pleomorphic Soft-Tissue Sarcoma With Red Fluorescent Protein for Rapid Non-Invasive Imaging for Drug Screening.
    Kiyuna T; Murakami T; Tome Y; Igarashi K; Kawaguchi K; Russell T; Eckardt MA; Crompton J; Singh A; Bernthal N; Bukata S; Federman N; Kanaya F; Eilber FC; Hoffman RM
    J Cell Biochem; 2017 Feb; 118(2):361-365. PubMed ID: 27357060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective antimetastatic activity of cytosine analog CS-682 in a red fluorescent protein orthotopic model of pancreatic cancer.
    Katz MH; Bouvet M; Takimoto S; Spivack D; Moossa AR; Hoffman RM
    Cancer Res; 2003 Sep; 63(17):5521-5. PubMed ID: 14500389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Incidence of Lymph-node Metastasis in a Pancreatic-cancer Patient-derived Orthotopic Xenograft (PDOX) NOG-Mouse Model.
    Sugisawa N; Miyake K; Higuchi T; Oshiro H; Park JH; Kawaguchi K; Bouvet M; Unno M; Hoffman RM
    Anticancer Res; 2022 Feb; 42(2):739-743. PubMed ID: 35093872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High correlation of whole-body red fluorescent protein imaging and magnetic resonance imaging on an orthotopic model of pancreatic cancer.
    Bouvet M; Spernyak J; Katz MH; Mazurchuk RV; Takimoto S; Bernacki R; Rustum YM; Moossa AR; Hoffman RM
    Cancer Res; 2005 Nov; 65(21):9829-33. PubMed ID: 16267005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visualization of GFP-expressing tumors and metastasis in vivo.
    Hoffman RM
    Biotechniques; 2001 May; 30(5):1016-22, 1024-6. PubMed ID: 11355337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive fluorescent-protein imaging of orthotopic pancreatic-cancer-patient tumorgraft progression in nude mice.
    Suetsugu A; Katz M; Fleming J; Truty M; Thomas R; Saji S; Moriwaki H; Bouvet M; Hoffman RM
    Anticancer Res; 2012 Aug; 32(8):3063-7. PubMed ID: 22843874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Stroma Labeling During Multiple Passage of a Sarcoma Imageable Patient-Derived Orthotopic Xenograft (iPDOX) in Red Fluorescent Protein Transgenic Nude Mice.
    Kiyuna T; Murakami T; Tome Y; Kawaguchi K; Igarashi K; Miyake K; Kanaya F; Singh A; Eilber FC; Hoffman RM
    J Cell Biochem; 2017 Oct; 118(10):3367-3371. PubMed ID: 28300287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Color-coded intravital imaging demonstrates a transforming growth factor-β (TGF-β) antagonist selectively targets stromal cells in a human pancreatic-cancer orthotopic mouse model.
    Murakami T; Hiroshima Y; Miyake K; Hwang HK; Kiyuna T; DeLong JC; Lwin TM; Matsuyama R; Mori R; Kumamoto T; Chishima T; Tanaka K; Ichikawa Y; Bouvet M; Endo I; Hoffman RM
    Cell Cycle; 2017 May; 16(10):1008-1014. PubMed ID: 28441080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.